Page last updated: 2024-09-05

dabigatran and Auricular Flutter

dabigatran has been researched along with Auricular Flutter in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	12 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hajšmanová, Z; Lavičková, A; Šigutová, P	1
Jesus, P; Monteiro, JMC; Oliveira Filho, J; San-Martin, DL; Silva, BCG; Souza, IFB	1
Ellis, CR; Kaiser, DW; Nagarakanti, R; Streur, MM; Whalen, SP	1
Han, SY; Lee, PY; Miyahara, RK	1
Amara, W; Guedeney, P; Iusuf, A	1
Groh, C; Passman, R; Yadlapati, A	1
Allouche, E; Amara, W; Dompnier, A; Fromentin, S; Georger, F; Nguyen, C; Saoudi, N; Taieb, J	1
Bode, C; Kelm, M; Zeus, T	1
Baker, D; Narasimhan, S; Wilsmore, B	1
Agdirlioglu, T; Borowski, M; Kellner, M; Reers, S; Reppel, M; Thiele, H; Waltenberger, J	1
Eckman, MH; Fang, MC; Go, AS; Halperin, JL; Howard, PA; Hughes, M; Hylek, EM; Lane, DA; Lip, GYH; Manning, WJ; Schulman, S; Singer, DE; Spencer, FA; You, JJ	1
Adachi, T; Isoda, K; Kimura, T; Yokoi, K	1

Reviews

1 review(s) available for dabigatran and Auricular Flutter

Article	Year
[Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure]. Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:16 Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Combined Modality Therapy; Contraindications; Dabigatran; Hemorrhage; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Thromboembolism; Vitamin K	2015

Article

Year

[Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure].

Deutsche medizinische Wochenschrift (1946), 2015, Volume: 140, Issue:16

Topics: Anticoagulants; Atrial Appendage; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Combined Modality Therapy; Contraindications; Dabigatran; Hemorrhage; Morpholines; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Thiophenes; Thromboembolism; Vitamin K

2015

Trials

1 trial(s) available for dabigatran and Auricular Flutter

Article	Year
Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists. European journal of medical research, 2016, Oct-21, Volume: 21, Issue:1 Topics: Aged; Atrial Fibrillation; Atrial Flutter; Atrial Function, Left; Dabigatran; Electrocardiography; Female; Heart Atria; Humans; Male; Middle Aged; Rivaroxaban; Thrombosis; Vitamin K	2016

Other Studies

10 other study(ies) available for dabigatran and Auricular Flutter

Article	Year
Repeated Administration of Idarucizumab to a Patient with Dabigatran Overdose. Hamostaseologie, 2018, Volume: 38, Issue:1 Topics: Aged; Antibodies, Monoclonal, Humanized; Atrial Flutter; Cerebral Infarction; Dabigatran; Drug Administration Schedule; Drug Overdose; Emergency Medical Services; Glomerular Filtration Rate; Humans; Male; Pericardiectomy; Renal Dialysis; Retreatment; Thrombin Time	2018
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil. Arquivos de neuro-psiquiatria, 2019, Volume: 77, Issue:2 Topics: Aged; Aged, 80 and over; Ambulatory Care Facilities; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Brazil; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Statistics, Nonparametric; Stroke; Thromboembolism; Treatment Outcome; Warfarin	2019
Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2013, Volume: 37, Issue:3 Topics: Adult; Anticoagulants; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Catheter Ablation; Comorbidity; Dabigatran; Embolism; Female; Humans; Incidence; Male; Middle Aged; Postoperative Complications; Premedication; Retrospective Studies; Risk Assessment; Stroke; Tennessee; Treatment Outcome; Warfarin	2013
Adherence and outcomes of patients treated with dabigatran: pharmacist-managed anticoagulation clinic versus usual care. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2013, Jul-01, Volume: 70, Issue:13 Topics: Adult; Aged; Antithrombins; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; California; Dabigatran; Female; Follow-Up Studies; Hospitals, Veterans; Humans; Male; Medication Adherence; Middle Aged; Pharmaceutical Services; Retrospective Studies; Stroke; Treatment Outcome	2013
[Ischemic stroke after cardioversion and atrial flutter ablation in a patient taking dabigatran]. Annales de cardiologie et d'angeiologie, 2013, Volume: 62, Issue:5 Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Atrial Flutter; Benzimidazoles; beta-Alanine; Catheter Ablation; Cerebral Arteries; Dabigatran; Echocardiography; Electric Countershock; Humans; Male; Stroke	2013
Safety of short-term use of dabigatran or rivaroxaban for direct-current cardioversion in patients with atrial fibrillation and atrial flutter. The American journal of cardiology, 2014, Apr-15, Volume: 113, Issue:8 Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Dabigatran; Dose-Response Relationship, Drug; Echocardiography, Transesophageal; Electric Countershock; Electrocardiography; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Morpholines; Retrospective Studies; Rivaroxaban; Thiophenes; Thromboembolism; Time Factors; Treatment Outcome	2014
New oral anticoagulants in patients undergoing atrial flutter radiofrequency catheter ablation: an observational study. Future cardiology, 2014, Volume: 10, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Flutter; Benzimidazoles; beta-Alanine; Catheter Ablation; Dabigatran; Female; Humans; Male; Middle Aged; Morpholines; Pilot Projects; Retrospective Studies; Rivaroxaban; Thiophenes; Treatment Outcome	2014
Adoption of direct oral anticoagulants for stroke prevention in atrial fibrillation. Internal medicine journal, 2016, Volume: 46, Issue:7 Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Australia; Dabigatran; Drug Prescriptions; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Pyrazoles; Pyridones; Retrospective Studies; Risk Factors; Rivaroxaban; Severity of Illness Index; Stroke; Warfarin	2016
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, Volume: 141, Issue:2 Suppl Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Countershock; Evidence-Based Medicine; Fibrinolytic Agents; Hemorrhage; Humans; International Normalized Ratio; Risk Factors; Societies, Medical; Stroke; Ticlopidine; Vitamin K	2012
Diffuse alveolar hemorrhage associated with dabigatran. Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:18 Topics: Aged; Antithrombins; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Lung Diseases; Male; Plasma; Radiography, Thoracic; Respiration, Artificial; Tomography, X-Ray Computed; Treatment Outcome	2012